Related Experiment Video
Updated: May 21, 2025

Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates
Published on: March 6, 2019
Structural Insights into Lipoate Ligase A-Mediated Antibody Modifications
Kazutoshi Takahashi1, Shunsuke Yamazaki1, Yutaka Matsuda1
1Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki, Kanagawa 210-8681, Japan.
Abstract:
Enzyme-mediated site-specific protein modification is gaining attention in biopharmaceuticals due to its high specificity and mild conditions. Lipoic acid ligase A (LplA) has been widely studied for conjugating short-chain fatty acids to lysine residues, traditionally using LAP tags. Recent advances have enabled tag-free LplA modifications, expanding applications in antibody-drug conjugates (ADCs) and beyond. This study investigates the selective modification of Lys188 in trastuzumab by LplA. Spatial analysis and molecular modeling suggest that D151 and H189 facilitate nucleophilic attack and stabilize intermediates via electrostatic and π-cation interactions. These insights enhance our understanding of enzyme-driven site selectivity, guiding the rational design of antibody modifications. The findings support broader applications in ADC production, diagnostics, and next-generation biopharmaceuticals, emphasizing the role of local amino acid environments in enzymatic modifications.
More Related Videos
Related Concept Videos
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Ligand Binding and Linkage
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

